Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.56 |
| ▸ | FNTA | P49354 | 5/20 | 0.54 |
| ▸ | FNTB | P49356 | 3/20 | 0.54 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.54 |
| ▸ | SQLE | Q14534 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL114886 | 1.00 | KMT2A (0.62) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL356732 | 1.00 | KMT2A (0.62) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL11617759 | 0.98 | KMT2A (0.67) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL15980322 | 0.98 | KMT2A (0.67) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL12967956 | 0.98 | KMT2A (0.67) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL1704911 | 0.98 | KMT2A (0.67) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL15980978 | 0.98 | KMT2A (0.67) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL15980982 | 0.98 | KMT2A (0.67) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL10127135 | 0.98 | KMT2A (0.67) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL11039524 | 0.86 | SQLE (0.54) | KMT2AALOX15ALDH1A1MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 650 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025108540-A1 | 5-METHYLCYCLOHEXANOLS AND DERIVATIVES AS FRAGRANCES | SYMRISE AG (DE) | 2025-05-30 | — | — | WO | claimed |
| US-20220364016-A1 | PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2022-11-17 | — | — | US | claimed |
| EP-4025675-A1 | A PERFUME OIL MIXTURE | Symrise AG (DE) | 2022-07-13 | — | — | EP | claimed |
| CN-109097350-B | Phoebe sesquiterpene synthetase SgSTPS2, and coding gene and application thereof | 中国林业科学研究院热带林业研究所 | 2021-04-27 | — | — | CN | claimed |
| WO-2021043585-A1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2021-03-11 | — | — | WO | claimed |
| US-20130267571-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | NEUROQUEST INC. (CA) | 2013-10-10 | — | — | US | claimed |
| EP-2616056-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | Neuroquest Inc. (CA) | 2013-07-24 | — | — | EP | claimed |
| EP-2134377-B1 | FRAGRANCE DISPENSER | SYMRISE AG (DE) | 2012-07-18 | — | — | EP | claimed |
| US-8191796-B2 | Fragrance dispenser | SYMRISE AG (DE) | 2012-06-05 | — | — | US | claimed |
| WO-2012034232-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | NEUROQUEST INC. (CA) | 2012-03-22 | — | — | WO | claimed |
| US-20090162308-A1 | USE OF 2,4'-DIMETHYLPROPIOPHENONE AS A FRAGRANCE SUBSTANCE | SYMRISE GMBH & CO. KG (DE) | 2009-06-25 | — | — | US | claimed |
| EP-2072083-A1 | Utilisation of 2.4'-dimethyl-propiophenon as an aroma | Symrise GmbH & Co. KG (DE) | 2009-06-24 | — | — | EP | claimed |
| WO-2008104226-A1 | FRAGRANCE DISPENSER | SYMRISE GMBH & CO. KG (DE) | 2008-09-04 | — | — | WO | claimed |
| US-20060166857-A1 | 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes | SYMRISE GMBH & CO. KG (DE) | 2006-07-27 | — | — | US | claimed |
| EP-1682230-A1 | 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES | Symrise GmbH & Co. KG (DE) | 2006-07-26 | — | — | EP | claimed |
| US-20060040218-A1 | Terpene ether solvents | WYATT MARION F | 2006-02-23 | — | — | US | claimed |
| WO-2005004825-A1 | 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES | SYMRISE GMBH & CO. KG (DE) | 2005-01-20 | — | — | WO | claimed |
| CN-87103789-A | Through improving the polydicyclopentadiene of smell | — | 1988-12-14 | — | — | CN | claimed |
| US-4731395-A | Polydicyclopentadiene having improved odor | HERCULES INCORPORATED (US) | 1988-03-15 | — | — | US | claimed |
| EP-0249032-A1 | Polydicyclopentadiene having improved odor | HERCULES INCORPORATED (US) | 1987-12-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090162308-A1 | USE OF 2,4'-DIMETHYLPROPIOPHENONE AS A FRAGRANCE SUBSTANCE | CYP1B1, CYP4A22, ROS1 | KMT2A 585/4885ALOX15 522/4885ALDH1A1 17/4885 |
| US-20130267571-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | PMP22, PTGES, GGPS1 | KMT2A 3842/4885ALOX15 22/4885ALDH1A1 1584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.